Followers | 3 |
Posts | 251 |
Boards Moderated | 0 |
Alias Born | 04/23/2013 |
Tuesday, February 27, 2018 10:18:18 AM
I waited until the new shareholders’ trading orgy predictably ended, to direct you to my few past warnings: I warned about our CEO’s checkered past, where in one case, his employees had to class-action sue him for their salaries before he finally settled and paid them.
Look up my posts (# 23108, 23686, and 23840) where I warned; this venture hinges on the CHARACTER of the CEO. They should have been included in the stickies. Those who refuse to consider the past are condemned to repeat it.
He is an established rogue CEO who was NEVER shareholder friendly. His playbook was originally exposed with Cobroxin, where shareholders constantly begged for PR’s with SUBSTANCE. Now, it’s simply; change the name to Nyloxin, then rinse, wash, repeat with a new set of gullible traders.
W.C. Fields famously stated: You can fool some of the people some of the time -- and that's enough to make a decent living.
Source: https://www.investorvillage.com/smbd.asp?mb=16383&mn=143&pt=msg&mid=9762569
Documentation beats conversation: This venture has devolved to where
a couple of frequent posters conduct themselves much like a borderline cultist, by being an apologist for the dismal past, while regurgitating the same old copy-and-paste posts over and over, along with confirmation bias, over-the-top conjecture and platitudes, accompanied by vapid teasing of upcoming PR’s, potential government contracts, VC buyouts, etc. As a former cult member during my youth, I’m very much aware of the markers.
Further, adulation of our CEO, in spite of his sketchy past, is known as the Stockholm Syndrome.
Thinking
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM